Alireza Dolatshahi-Pirouz

Nov 12, 2024 | ehu.eus | Yu ZHANG |Alireza Dolatshahi-Pirouz |Gorka Orive

Gorka Orive, investigador del grupo NanoBioCel de la Universidad del País Vasco, analiza en un artículo colaborativo el potencial, las limitaciones y los retos que tiene la bioimpresión 3D en el ámbito de la regeneración de tejidos. Los investigadores consideran necesario superar los problemas de la escasa densidad celular imprimida, conseguir dar a cada tejido las características correspondientes y llegar a aplicar esta biofabricación directamente “a pie de cama”.

Aug 8, 2024 | science.org | Pengfei Guo |Marcos Dantus |Yu ZHANG |Alireza Dolatshahi-Pirouz

Regenerative medicine uses viable cells that are injected, grafted, or implanted into a patient to exert a desired therapeutic effect, such as healing of traumatic wounds. However, achieving efficient delivery of therapeutic cells to the target site, without loss of survival and function, and ensuring tissue integration are among the key challenges to success.

May 11, 2024 | ehu.eus | Yu ZHANG |Alireza Dolatshahi-Pirouz |Gorka Orive

In a collaborative article Gorka Orive, a researcher in the UPV/EHU’s NanoBioCel group, explores the potential and limitations of 3D bioprinting as well as the challenges it faces in the area of tissue regeneration. Researchers say the problems of poor printed cell density need to be overcome, each tissue needs to be provided with the corresponding characteristics, and this direct bedside biofabrication needs to be achieved.